We have recently shown that leptin enhances systemic insulin sensitivity an
d whole body glucose utilization in the rat. This study examines our hypoth
esis that leptin has differential effects in regulating glucose utilization
among the tissues, i.e. stimulating glucose utilization in brown adipose t
issue (BAT) and skeletal muscle but suppressing glucose utilization in whit
e adipose tissue (WAT) in normal male rats (275-350 g BW). The rats were tr
eated with sc infusion of recombinant murine leptin (4 mg/kg day) or vehicl
e (V) with Alzet osmotic pumps or with Vehicle and pair-feeding (PF) for 7
days. Leptin significantly decreased food intake (leptin, 11.5 +/- 0.4 g/da
y; V, 16.8 +/- 1.5 g/day; P < 0.05) and body weight (maximum change, 5.0 +/
- 0.2%; P < 0.05 vs. V) and lowered plasma triglyceride, insulin, and gluco
se levels, but raised P-hydroxybutyrate levels. Glucose utilization by indi
vidual tissues was determined with an iv bolus of [1-C-14]2-deoxyglucose (2
-DG) after a 90-min hyperinsulinemic (2 mU/kg min) euglycemic clamp. With l
eptin treatment, the e-DG-determined glucose utilization in interscapular B
AT was almost 3-fold that in V-treated rats and 70% greater than that in PF
rats. In contrast, in the epididymal WAT, glucose utilization was reduced
by leptin treatment to only 34% that in V-treated rats and 45% that in PP r
ats. Leptin increased 2-DG uptake by extensor digitorum longus muscle and s
oleus muscle compared with that in the V and PF groups. With leptin treatme
nt, the GLUT4 glucose transporter mRNA and protein levels were increased in
BAT, but decreased in WAT (both P < 0.05). There was no significant change
in GLUT4 mRNA and protein expression in extensor digitorum longus muscle a
nd soleus muscle. Oxygen consumption was significantly increased (32.1 +/-
7.4%) in BAT (139.0 +/- 8.2 nmole O-2/30 min 10(6) cells) of leptin-treated
rats us. that in V control rats (105.3 +/- 6.7 nmole O-2/30 min 10(6) cell
s). In conclusion, leptin has differential, tissue-specific effects on gluc
ose and oxygen utilization, which contribute to the reduction in whole body
adiposity by enhancing energy consumption in BAT and muscle while attenuat
ing energy storage in WAT.